search
Back to results

Evaluating Patient Information Prescriptions

Primary Purpose

Breast Neoplasms, Premature Birth

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Information Services (IRx)
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Neoplasms focused on measuring Information Services, Randomized Controlled Trials, Medical Records Systems, Computerized, Internet, Librarians, Breast Neoplasms, Patient Satisfaction, Health Personnel, Costs and Cost Analysis, Premature Birth

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Breast Cancer: any new patient seen in Johns Hopkins medical oncology for Breast Cancer Neonatal Intensive care:Biological mothers (or consenting guardians) of premature infants born and admitted or transferred in to Johns Hopkins Hospital or Bayview Medical Center neonatal intensive care units. Exclusion Criteria: Breast Cancer: None Neonatal Intensive Care: Parents with infants whose SNAP mortality >= 80%(J Pediatr. 2001 Jan;138(1):92-100)

Sites / Locations

  • Johns Hopkins School of Medicine

Outcomes

Primary Outcome Measures

Patient Satisfaction

Secondary Outcome Measures

provider perceptions and behavior will be assessed;costs entailed and resources utilized will be assessed;how the intervention (information services) generalizes across service environments

Full Information

First Posted
July 19, 2006
Last Updated
October 19, 2018
Sponsor
Johns Hopkins University
Collaborators
National Institutes of Health (NIH), National Library of Medicine (NLM)
search

1. Study Identification

Unique Protocol Identification Number
NCT00355381
Brief Title
Evaluating Patient Information Prescriptions
Official Title
Evaluating Patient Information Prescriptions in Different Service Environments
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
September 2004 (undefined)
Primary Completion Date
April 2008 (Actual)
Study Completion Date
September 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
National Institutes of Health (NIH), National Library of Medicine (NLM)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Research shows that patient satisfaction with medical care correlates strongly with how satisfied they are with the ease of getting information from their providers regarding their medical condition. Although the Internet is a wonderful source of information for patients, research has shown that, unmediated, it comprises a potential quagmire of information poorly matched to users needs. Providers typically do not have enough time to fulfill all of their patients' information needs. One strategy to meeting the patient's information needs is to introduce librarians trained and experienced in consumer health information services into the relationship between the patient and the provider. One recently described tactic is for providers to provide information the way they of provide treatment-through an information prescription (IRx) filled by a librarian. The librarian fills the prescription by offering information services tailored to the needs of individual patients. At Johns Hopkins, we have piloted such a tactic, and in this project, extend and evaluate it. The research hypothesis is that provision of an IRx will improve patient satisfaction, provider knowledge and attitudes regarding patient information needs, and the efficiencies of care.
Detailed Description
The goal of this research is to evaluate IRx, to provide enough data so care organizations can decide whether to implement this in their own environment. To that end, our specific aims are: To evaluate the impact of IRx on patients. We are performing a randomized clinical trial, comparing IRx with standard provision of information. The primary outcome is patient satisfaction. To evaluate the impact of IRx on providers. As part of the trial, provider perceptions and behavior will be assessed. To evaluate the impact of IRx on the health-care system. As part of the trial, costs entailed and resources utilized will be assessed. To evaluate how IRx generalizes across service environments. The trial will be performed in two environments: adult breast cancer and neonatal intensive care. At the heart of this proposal are the randomized clinical trials. In each, patients in both intervention and control groups will receive standard clinical care in their clinic visits. Patients randomized to the intervention group will receive information services from a specially trained librarian; patients in the control groups will receive routine, current information provision. For Aim 1, immediately after their clinic visits and four weeks later, all participants will report their satisfaction on a survey that include measures of patient-provider communication. For Aim 2, participating providers are surveyed for their perceptions of information needs being met and about patient-provider interaction. For Aim 3, costs of care and costs of providing the IRx environment will be tabulated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasms, Premature Birth
Keywords
Information Services, Randomized Controlled Trials, Medical Records Systems, Computerized, Internet, Librarians, Breast Neoplasms, Patient Satisfaction, Health Personnel, Costs and Cost Analysis, Premature Birth

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
299 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Information Services (IRx)
Other Intervention Name(s)
Information prescriptions or IRx
Intervention Description
Information services tailored to the needs of individual patients. The information prescription (IRx)or service is defined for this study as a combination of: 1)An evidence-based web site for use by patients and their families; 2) A reference interview and assistance in locating relevant general information in response to patient information needs; 3) Documentation of the questions and the information service provided in response to these in the patient's Electronic Patient Record for review by providers as needed; and, 4) Triage of patient's/parents clinical questions to providers.
Primary Outcome Measure Information:
Title
Patient Satisfaction
Time Frame
4 years
Secondary Outcome Measure Information:
Title
provider perceptions and behavior will be assessed;costs entailed and resources utilized will be assessed;how the intervention (information services) generalizes across service environments
Time Frame
4 years

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Breast Cancer: any new patient seen in Johns Hopkins medical oncology for Breast Cancer Neonatal Intensive care:Biological mothers (or consenting guardians) of premature infants born and admitted or transferred in to Johns Hopkins Hospital or Bayview Medical Center neonatal intensive care units. Exclusion Criteria: Breast Cancer: None Neonatal Intensive Care: Parents with infants whose SNAP mortality >= 80%(J Pediatr. 2001 Jan;138(1):92-100)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nancy K Oliver, MLS
Organizational Affiliation
Johns Hopkins School of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kathleen B Oliver, MLS, MPH
Organizational Affiliation
Johns Hopkins School of Medicine
Official's Role
Study Director
Facility Information:
Facility Name
Johns Hopkins School of Medicine
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21205
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluating Patient Information Prescriptions

We'll reach out to this number within 24 hrs